Fatih Oguz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fatih Oguz has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Hakan Parlakpinar
Department of Pharmacology, Faculty of Medicine, Inonu University, Malatya, Turkey
5 shared publications A. Beytur
4 shared publications- Ayşe Kristina Polat
Department of Neurology, Sakarya Training and Research Hospital, Turkey
4 shared publications Ali Beytur
Inonu University, School of Medicine, Department of Urology, Malatya, Turkey
3 shared publicationsIlhan Gecit
Department of Urology, Inonu University Faculty of Medicine, Malatya, Türkiye
2 shared publications- İbRahim Topcu
Department of Urology, Faculty of Medicine, İnönü University, 44280 Malatya, Türkiye
2 shared publications
Latest Publications
- 8 October 2026
- Published by Inonu University in İnönü Üniversitesi Sağlık Hizmetleri Meslek Yüksek Okulu Dergisi
- No. Advanced O
Metabolic and Radiological Characteristics of Nephrolithiasis in Liver Transplant Candidates and Donors: A Retrospective Comparative Cohort Study
Nephrolithiasis is a globally prevalent condition with increasing incidence; however, its occurrence in patients with end-stage liver disease awaiting liver transplantation is less well known. The aim of this study is to evaluate and compare the prevalence and characteristics of kidney stones, the occurrence of stone-related surgery, the findings of urinalysis, and certain serum biomarkers in liver transplant candidates and liver donors. A total of 4970 individuals, 2485 liver transplant candidates and 2485 liver transplant donors, were scanned for nephrolithiasis. Kidney stones were detected in 85 (3.42%) liver transplant candidates and 71 (2.86%) liver transplant donors, and the male-to-female ratio was 3.72:1 among the transplant candidatesand 2.23:1 among the transplant donors. The median stone size and density were significantly higher in the transplant candidate group than in the donor group. Although urine pH and serum uric acid levels were significantly higher in the transplant candidates, no significant differences were detected in urine specific gravity, serum creatinine levels, or the percentage with a history of stone-related surgery. These findings suggest that hepatic dysfunction may be associated with larger and denser stones and altered biochemical parameters, although its role in increasing stone prevalence should be interpreted with caution.
- 8 October 2026
- Published by Inonu University in İnönü Üniversitesi Sağlık Hizmetleri Meslek Yüksek Okulu Dergisi
- No. Advanced O
Metabolic and Radiological Characteristics of Nephrolithiasis in Liver Transplant Candidates and Donors: A Retrospective Comparative Cohort Study
Nephrolithiasis is a globally prevalent condition with increasing incidence; however, its occurrence in patients with end-stage liver disease awaiting liver transplantation is less well known. The aim of this study is to evaluate and compare the prevalence and characteristics of kidney stones, the occurrence of stone-related surgery, the findings of urinalysis, and certain serum biomarkers in liver transplant candidates and liver donors. A total of 4970 individuals, 2485 liver transplant candidates and 2485 liver transplant donors, were scanned for nephrolithiasis. Kidney stones were detected in 85 (3.42%) liver transplant candidates and 71 (2.86%) liver transplant donors, and the male-to-female ratio was 3.72:1 among the transplant candidatesand 2.23:1 among the transplant donors. The median stone size and density were significantly higher in the transplant candidate group than in the donor group. Although urine pH and serum uric acid levels were significantly higher in the transplant candidates, no significant differences were detected in urine specific gravity, serum creatinine levels, or the percentage with a history of stone-related surgery. These findings suggest that hepatic dysfunction may be associated with larger and denser stones and altered biochemical parameters, although its role in increasing stone prevalence should be interpreted with caution.
- Open Access
- 30 August 2023
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 51 (8)
Efficacy and safety of Hyadex for treatment of vesicoureteral reflux: a multicenter experience
Objective: This study was performed to evaluate the efficacy and safety of dextranomer/cross-linked hyaluronic acid (Hyadex) in patients with a clinical diagnosis of vesicoureteral reflux (VUR). Methods: In this cross-sectional multicenter observational study, Hyadex was used in four different centers for the endoscopic treatment of VUR from 2020 to 2022. The study involved 74 patients (93 renal units) who were diagnosed with VUR according to voiding cystourethrography (VCUG) findings and were considered suitable for subureteric endoscopic treatment. The follow-up time (control VCUG time) was 3 months. Results: In the VCUG evaluation, grade I VUR was found in 13 renal units, grade II in 23 renal units, grade III in 42 renal units, and grade IV in 12 renal units. The success rates of Hyadex treatment according to the degree of VUR were as follows: 84.6% for grade I, 82.6% for grade II, 71.4% for grade III, and 66.0% for grade IV. No major complications were observed. Conclusion: Endoscopic subureteric Hyadex injection had high success rates in appropriately selected patients with VUR and may be used as the first-line treatment for children with VUR.
- 30 August 2023
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 51 (8)
Open AccessEfficacy and safety of Hyadex for treatment of vesicoureteral reflux: a multicenter experience
Objective: This study was performed to evaluate the efficacy and safety of dextranomer/cross-linked hyaluronic acid (Hyadex) in patients with a clinical diagnosis of vesicoureteral reflux (VUR). Methods: In this cross-sectional multicenter observational study, Hyadex was used in four different centers for the endoscopic treatment of VUR from 2020 to 2022. The study involved 74 patients (93 renal units) who were diagnosed with VUR according to voiding cystourethrography (VCUG) findings and were considered suitable for subureteric endoscopic treatment. The follow-up time (control VCUG time) was 3 months. Results: In the VCUG evaluation, grade I VUR was found in 13 renal units, grade II in 23 renal units, grade III in 42 renal units, and grade IV in 12 renal units. The success rates of Hyadex treatment according to the degree of VUR were as follows: 84.6% for grade I, 82.6% for grade II, 71.4% for grade III, and 66.0% for grade IV. No major complications were observed. Conclusion: Endoscopic subureteric Hyadex injection had high success rates in appropriately selected patients with VUR and may be used as the first-line treatment for children with VUR.
- Open Access
- 1 January 2023
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 53 (1) , 264-272
Use of dual energy CT urography in evaluation of urinary stone and complex cyst
Background/aim: Dual-energy computed tomography scans can provide significant benefits to the urinary system. The aim of this study is to determine the limitations and benefits of using dual energy CT urography in patients with urinary system stones and cysts. Materials and methods: In the analysis of the images, the virtual noncontrasted images obtained from the combined nephrogenicexcretory phase and the true noncontrasted images were evaluated. The true noncontrast images were accepted as the gold standard for stone detection. Results: Eighty-three different stones were detected in 26 of the 115 patients included in the study. Sensibilities of virtual noncontrast images in detecting urinary system stones were 66.7% and 65.4% according to the first and second radiologists, respectively. In this study, 32 hyperdense cysts were detected. According to iodine map images, there was no enhancement in 26 of 32 cysts; only 5 cysts showed minimal contrast enhancement. One patient could not decide on contrast enhancement. Conclusion: As a result, if CT urography is performed with dual energy, it can provide additional information in patients with urinary system disorder.
- 1 January 2023
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 53 (1) , 264-272
Open AccessUse of dual energy CT urography in evaluation of urinary stone and complex cyst
Background/aim: Dual-energy computed tomography scans can provide significant benefits to the urinary system. The aim of this study is to determine the limitations and benefits of using dual energy CT urography in patients with urinary system stones and cysts. Materials and methods: In the analysis of the images, the virtual noncontrasted images obtained from the combined nephrogenicexcretory phase and the true noncontrasted images were evaluated. The true noncontrast images were accepted as the gold standard for stone detection. Results: Eighty-three different stones were detected in 26 of the 115 patients included in the study. Sensibilities of virtual noncontrast images in detecting urinary system stones were 66.7% and 65.4% according to the first and second radiologists, respectively. In this study, 32 hyperdense cysts were detected. According to iodine map images, there was no enhancement in 26 of 32 cysts; only 5 cysts showed minimal contrast enhancement. One patient could not decide on contrast enhancement. Conclusion: As a result, if CT urography is performed with dual energy, it can provide additional information in patients with urinary system disorder.
- 22 September 2022
- Published by Galenos Yayinevi in Cyprus Journal of Medical Sciences
- Vol. 7 (4) , 429-430
A Rare Complication of a Rare Disease; Spontaneous Bladder Perforation in a Case of Emphysematous Cystitis
- 22 September 2022
- Published by Galenos Yayinevi in Cyprus Journal of Medical Sciences
- Vol. 7 (4) , 429-430
A Rare Complication of a Rare Disease; Spontaneous Bladder Perforation in a Case of Emphysematous Cystitis
- Open Access
- 1 December 2019
- Vol. 22 (12) , 1392-1399
Evaluation of reproductive and renal toxicity of varenicline in male rats
Objective(s): Varenicline is a selective partial agonist for the nicotinic acetylcholine receptor a4b2 subtype, which is widely used to treat smoking addiction. However, there is still no data about its potential toxic effects on tissues. In this study, we aimed to determine the varenicline-induced toxicity on reproductive and renal tissues in rats.Materials and Methods: Rats were randomly divided into two groups: control (n=10) and varenicline (n=24). Then, rats in each group were sub-divided equally as acute and chronic groups. The control rats were orally given distilled water only. Varenicline was administrated orally as follows: 1st–3rd days 9 µg/kg/day, 4th–7th days 9 µg/kg twice daily, and 8th–90th days 18 µg/kg twice daily. The rats of acute and chronic groups were sacrificed on the 45th and 90th days, respectively. Some tissue markers related to oxidative stress were measured, and sperm characteristics were observed.Results: In the acute group, varenicline led to a significant decrease in SOD activities in both kidney and testis tissues. In the chronic group, varenicline significantly increased MDA and MPO production, and reduced CAT and GPx levels in the kidneys and testes. Also, SOD and GSH levels significantly decreased in the testes. Moreover, sperm characteristics were negatively affected; histopathological deformation was observed in the testes and kidneys in all groups.Conclusion: This study showed that varenicline could detrimentally affect the kidneys and testes in both acute and chronic term usage. Further studies will provide more insights into the molecular dynamics of this damage.
- 1 December 2019
- Vol. 22 (12) , 1392-1399
Open AccessEvaluation of reproductive and renal toxicity of varenicline in male rats
Objective(s): Varenicline is a selective partial agonist for the nicotinic acetylcholine receptor a4b2 subtype, which is widely used to treat smoking addiction. However, there is still no data about its potential toxic effects on tissues. In this study, we aimed to determine the varenicline-induced toxicity on reproductive and renal tissues in rats.Materials and Methods: Rats were randomly divided into two groups: control (n=10) and varenicline (n=24). Then, rats in each group were sub-divided equally as acute and chronic groups. The control rats were orally given distilled water only. Varenicline was administrated orally as follows: 1st–3rd days 9 µg/kg/day, 4th–7th days 9 µg/kg twice daily, and 8th–90th days 18 µg/kg twice daily. The rats of acute and chronic groups were sacrificed on the 45th and 90th days, respectively. Some tissue markers related to oxidative stress were measured, and sperm characteristics were observed.Results: In the acute group, varenicline led to a significant decrease in SOD activities in both kidney and testis tissues. In the chronic group, varenicline significantly increased MDA and MPO production, and reduced CAT and GPx levels in the kidneys and testes. Also, SOD and GSH levels significantly decreased in the testes. Moreover, sperm characteristics were negatively affected; histopathological deformation was observed in the testes and kidneys in all groups.Conclusion: This study showed that varenicline could detrimentally affect the kidneys and testes in both acute and chronic term usage. Further studies will provide more insights into the molecular dynamics of this damage.
- Open Access
- 16 July 2019
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 47 (9) , 4225-4229
Comparing 2% lidocaine gel (Dispogel and Cathejell) in cystoscopy
Objective: Cystoscopy is a common urologic procedure. Analgesics are often used to reduce any pain associated with this procedure. The aim of this study was to investigate the efficacy in reducing pain and the cost-effectiveness of two forms of lidocaine gel in patients undergoing cystoscopy. Methods: In this double-blind, randomized clinical trial, 77 male patients who were referred for double J removal, urethral dilatation, or cystoscopy were enrolled. The patients were divided into two groups: Dispogel and Cathejell. All patients received 20 mL of intraurethral lidocaine gel 2% and cystoscopy was performed 5 minutes thereafter. The primary outcome was the pain score (visual analogue scale, VAS) during and 5 minutes after cystoscopy. Results: There were no statistically significant differences between the VAS scores, blood pressure, and pulse rate in the groups in either observation period. No patient required additional anesthetic agents or sedatives for insufficient pain relief. Conclusion: The results of this study show that the analgesic efficacy of Dispogel and Cathejell in the treatment of pain during and after elective cystoscopy was the same, but Dispogel was more cost-effective.
- 16 July 2019
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 47 (9) , 4225-4229
Open AccessComparing 2% lidocaine gel (Dispogel and Cathejell) in cystoscopy
Objective: Cystoscopy is a common urologic procedure. Analgesics are often used to reduce any pain associated with this procedure. The aim of this study was to investigate the efficacy in reducing pain and the cost-effectiveness of two forms of lidocaine gel in patients undergoing cystoscopy. Methods: In this double-blind, randomized clinical trial, 77 male patients who were referred for double J removal, urethral dilatation, or cystoscopy were enrolled. The patients were divided into two groups: Dispogel and Cathejell. All patients received 20 mL of intraurethral lidocaine gel 2% and cystoscopy was performed 5 minutes thereafter. The primary outcome was the pain score (visual analogue scale, VAS) during and 5 minutes after cystoscopy. Results: There were no statistically significant differences between the VAS scores, blood pressure, and pulse rate in the groups in either observation period. No patient required additional anesthetic agents or sedatives for insufficient pain relief. Conclusion: The results of this study show that the analgesic efficacy of Dispogel and Cathejell in the treatment of pain during and after elective cystoscopy was the same, but Dispogel was more cost-effective.
- Open Access
- 1 February 2016
- Published by University of Toronto Press Inc. (UTPress) in Clinical & Investigative Medicine
- Vol. 39 (1) , E7-E14
Protective effects of molsidomine against doxorubicin-induced renal damage in rats
Purpose: The purpose of this study was to investigate the therapeutic and protective effects of molsidomine (MLS) against doxorubicin (DOX)-induced renal damage in rats. Methods: Forty rats were randomly divided into five groups (control, MLS, DOX, DOX+MLS and MLS+DOX groups). Thiobarbituric acid reactive substance (TBARS), reduced glutathione (GSH), superoxide dismutase (SOD), catalase (CAT), nitric oxide (NO) and glutathione peroxidase (GPx) levels were determined from kidney tissues and blood urea nitrogen (BUN), creatinine (Cr) and albumin (Alb) levels also determined. Results: DOX treatment caused a significant increase in TBARS levels and a significant decrease in the GSH and CAT levels compared with the control group. In comparison, MLS administration before DOX injection caused a significant decrease in TBARS levels and also increases in GSH and CAT levels, whereas treatment of MLS after DOX injection did not show any beneficial effect on these parameters. All groups showed a significant increase in NO levels compared to the control group. There were no significant differences among the all groups for BUN and Cr levels. Serum level of Alb decreased in the DOX-treated groups when compared with control and MLS groups. The histopathological findings were in accordance with the biochemical results. MLS treatment reversed the DOX-induced kidney damage in group 4. MLS treatment before DOX injection exerted a protective effect against DOX-induced kidney damage. Conclusions: MLS shows promise as a possible therapeutic intervention for the prevention of kidney injury associated with DOX treatment. Additional studies are warranted.
- 1 February 2016
- Published by University of Toronto Press Inc. (UTPress) in Clinical & Investigative Medicine
- Vol. 39 (1) , E7-E14
Open AccessProtective effects of molsidomine against doxorubicin-induced renal damage in rats
Purpose: The purpose of this study was to investigate the therapeutic and protective effects of molsidomine (MLS) against doxorubicin (DOX)-induced renal damage in rats. Methods: Forty rats were randomly divided into five groups (control, MLS, DOX, DOX+MLS and MLS+DOX groups). Thiobarbituric acid reactive substance (TBARS), reduced glutathione (GSH), superoxide dismutase (SOD), catalase (CAT), nitric oxide (NO) and glutathione peroxidase (GPx) levels were determined from kidney tissues and blood urea nitrogen (BUN), creatinine (Cr) and albumin (Alb) levels also determined. Results: DOX treatment caused a significant increase in TBARS levels and a significant decrease in the GSH and CAT levels compared with the control group. In comparison, MLS administration before DOX injection caused a significant decrease in TBARS levels and also increases in GSH and CAT levels, whereas treatment of MLS after DOX injection did not show any beneficial effect on these parameters. All groups showed a significant increase in NO levels compared to the control group. There were no significant differences among the all groups for BUN and Cr levels. Serum level of Alb decreased in the DOX-treated groups when compared with control and MLS groups. The histopathological findings were in accordance with the biochemical results. MLS treatment reversed the DOX-induced kidney damage in group 4. MLS treatment before DOX injection exerted a protective effect against DOX-induced kidney damage. Conclusions: MLS shows promise as a possible therapeutic intervention for the prevention of kidney injury associated with DOX treatment. Additional studies are warranted.
- 18 December 2013
- Published by Hindawi Limited in Andrologia
- Vol. 46 (10) , 1161-1168
Fish oil, contained in eicosapentaenoic acid and docosahexaenoic acid, attenuates testicular and spermatological damage induced by cisplatin in rats
The aim of this study was to investigate the beneficial effects of the fish oil (FO) supplementation on oxidative stress, sperm characteristics and histological alterations in the male reproductive system of rats against cisplatin (CP) toxicity. The rats were divided randomly into 4 equal groups (control, FO, CP and FO + CP). FO was orally administered at the dose of 1 softgel per rat per day for 14 days and CP was intraperitoneally given at the dose of 7 mg kg(-1) with a single injection. In CP + FO group, they were applicated at the same doses and times. The results showed that CP caused a significant oxidative damage via induction of lipid peroxidation and reduction in the antioxidant defence system potency in the testis tissue. In addition, sperm motility and sperm concentration significantly decreased but the abnormal sperm rate and histopathological testicular damage increased with CP treatment. On the other hand, FO treatment prevented oxidative, histopathological and spermatological effects of CP and reversed side effects of CP. In conclusion, FO supplementation had significant beneficial effects against CP toxicity on male reproductive system and toxic effects of CP can be prevented by FO treatment. Therefore, it appears that fish oil may be useful for the prevention and treatment of cisplatin-induced reproductive system toxicity.
- 18 December 2013
- Published by Hindawi Limited in Andrologia
- Vol. 46 (10) , 1161-1168
Fish oil, contained in eicosapentaenoic acid and docosahexaenoic acid, attenuates testicular and spermatological damage induced by cisplatin in rats
The aim of this study was to investigate the beneficial effects of the fish oil (FO) supplementation on oxidative stress, sperm characteristics and histological alterations in the male reproductive system of rats against cisplatin (CP) toxicity. The rats were divided randomly into 4 equal groups (control, FO, CP and FO + CP). FO was orally administered at the dose of 1 softgel per rat per day for 14 days and CP was intraperitoneally given at the dose of 7 mg kg(-1) with a single injection. In CP + FO group, they were applicated at the same doses and times. The results showed that CP caused a significant oxidative damage via induction of lipid peroxidation and reduction in the antioxidant defence system potency in the testis tissue. In addition, sperm motility and sperm concentration significantly decreased but the abnormal sperm rate and histopathological testicular damage increased with CP treatment. On the other hand, FO treatment prevented oxidative, histopathological and spermatological effects of CP and reversed side effects of CP. In conclusion, FO supplementation had significant beneficial effects against CP toxicity on male reproductive system and toxic effects of CP can be prevented by FO treatment. Therefore, it appears that fish oil may be useful for the prevention and treatment of cisplatin-induced reproductive system toxicity.
- 28 May 2013
- Published by Springer Nature in Urolithiasis
- Vol. 41 (4) , 365
How safe is the monoplanar access technique for percutaneous nephrolithotomy?
- 28 May 2013
- Published by Springer Nature in Urolithiasis
- Vol. 41 (4) , 365
How safe is the monoplanar access technique for percutaneous nephrolithotomy?
- 1 March 2013
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 10 (3) , 838-843
Is There a Relationship Between Chronic Periodontitis and Erectile Dysfunction?
Chronic periodontitis (CP) is characterized with inflammation of the gingival tissues, which causes endothelial dysfunction in different organs. In this study, we investigated the association of CP with the erectile dysfunction (ED). The study group included 80 male patients with ED and 82 male patients without ED (control), aged between 30 and 40 years. The International Index of Erectile Function (IIEF) questionnaire was used to assess male sexual function, particularly the presence or absence of ED. The patients in the study and control groups were statistically compared according to their plaque index (PI), bleeding on probing (BoP), probing depth (PD), and clinical attachment level (CAL). In the non-ED and the ED groups, the mean age was 35.7 ± 4.8 and 34.9 ± 4.9 years, respectively. Patients' characteristics including body mass index, household income, and education status were similar in both groups (P > 0.05). Nineteen patients (23%) had severe CP in the non-ED group; 42 patients (53%) had severe CP in the ED group. Logistic regression analysis showed a significantly high association between ED and the severity of CP (odds ratio: 3.29, 95% confidence interval: 1.36-9.55, P < 0.01). The mean values of PI, BoP, and the percentages of sites with PD >4 mm and sites with CAL >4 mm were significantly higher in the ED group than in the control group (P < 0.05). The mean values of PD and CAL were not significantly different in the two groups (P > 0.05). The decayed, missing, filled teeth scores were also significantly higher in the ED group than in the non-ED group (P < 0.05). Our results have suggested that CP had a high association with ED in young adults at 30-40 years. We think that it will be of benefit to consider periodontal disease as a causative clinical condition of ED in such patients.
- 1 March 2013
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 10 (3) , 838-843
Is There a Relationship Between Chronic Periodontitis and Erectile Dysfunction?
Chronic periodontitis (CP) is characterized with inflammation of the gingival tissues, which causes endothelial dysfunction in different organs. In this study, we investigated the association of CP with the erectile dysfunction (ED). The study group included 80 male patients with ED and 82 male patients without ED (control), aged between 30 and 40 years. The International Index of Erectile Function (IIEF) questionnaire was used to assess male sexual function, particularly the presence or absence of ED. The patients in the study and control groups were statistically compared according to their plaque index (PI), bleeding on probing (BoP), probing depth (PD), and clinical attachment level (CAL). In the non-ED and the ED groups, the mean age was 35.7 ± 4.8 and 34.9 ± 4.9 years, respectively. Patients' characteristics including body mass index, household income, and education status were similar in both groups (P > 0.05). Nineteen patients (23%) had severe CP in the non-ED group; 42 patients (53%) had severe CP in the ED group. Logistic regression analysis showed a significantly high association between ED and the severity of CP (odds ratio: 3.29, 95% confidence interval: 1.36-9.55, P < 0.01). The mean values of PI, BoP, and the percentages of sites with PD >4 mm and sites with CAL >4 mm were significantly higher in the ED group than in the control group (P < 0.05). The mean values of PD and CAL were not significantly different in the two groups (P > 0.05). The decayed, missing, filled teeth scores were also significantly higher in the ED group than in the non-ED group (P < 0.05). Our results have suggested that CP had a high association with ED in young adults at 30-40 years. We think that it will be of benefit to consider periodontal disease as a causative clinical condition of ED in such patients.